These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 19775658)

  • 1. Subclassification of ovarian cancer based on pathology and genetics.
    Prat J
    Eur J Cancer; 2009 Sep; 45 Suppl 1():427-8. PubMed ID: 19775658
    [No Abstract]   [Full Text] [Related]  

  • 2. Subdividing ovarian and peritoneal serous carcinoma into moderately differentiated and poorly differentiated does not have biologic validity based on molecular genetic and in vitro drug resistance data.
    Vang R; Shih IeM; Salani R; Sugar E; Ayhan A; Kurman RJ
    Am J Surg Pathol; 2008 Nov; 32(11):1667-74. PubMed ID: 18769340
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ovarian carcinoma pathology and genetics: recent advances.
    Gilks CB; Prat J
    Hum Pathol; 2009 Sep; 40(9):1213-23. PubMed ID: 19552940
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular biology and genetics of epithelial ovarian cancer.
    Baker VV
    Obstet Gynecol Clin North Am; 1994 Mar; 21(1):25-40. PubMed ID: 8015765
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ovarian pathology in risk-reducing salpingo-oophorectomies from women with BRCA mutations, emphasizing the differential diagnosis of occult primary and metastatic carcinoma.
    Rabban JT; Barnes M; Chen LM; Powell CB; Crawford B; Zaloudek CJ
    Am J Surg Pathol; 2009 Aug; 33(8):1125-36. PubMed ID: 19440148
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recent advances in the pathology and classification of ovarian germ cell tumors.
    Roth LM; Talerman A
    Int J Gynecol Pathol; 2006 Oct; 25(4):305-20. PubMed ID: 16990705
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Probability of BRCA1/2 mutation varies with ovarian histology: results from screening 442 ovarian cancer families.
    Evans DG; Young K; Bulman M; Shenton A; Wallace A; Lalloo F
    Clin Genet; 2008 Apr; 73(4):338-45. PubMed ID: 18312450
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pathology of epithelial ovarian cancer.
    Tornos C; Silva EG
    Obstet Gynecol Clin North Am; 1994 Mar; 21(1):63-77. PubMed ID: 8015767
    [TBL] [Abstract][Full Text] [Related]  

  • 9. BRCA1 and BRCA2 mutation prevalence and clinical characteristics of a population-based series of ovarian cancer cases from Denmark.
    Soegaard M; Kjaer SK; Cox M; Wozniak E; Høgdall E; Høgdall C; Blaakaer J; Jacobs IJ; Gayther SA; Ramus SJ
    Clin Cancer Res; 2008 Jun; 14(12):3761-7. PubMed ID: 18559594
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [BRCA2 gene mutation detection in hereditary ovarian cancer tissues].
    Qiao Y; Chen P; Shi H; Zhao G; Wu D
    Zhonghua Fu Chan Ke Za Zhi; 2002 Jun; 37(6):349-51. PubMed ID: 12126570
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Breast and ovarian cancer: genetic update and implications for nursing.
    Lessick M; Wickham R; Rehwaldt M
    Medsurg Nurs; 1997 Dec; 6(6):341-9. PubMed ID: 9429406
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Overexpression and mutation of p53 in epithelial ovarian cancer.
    Marks JR; Davidoff AM; Kerns BJ; Humphrey PA; Pence JC; Dodge RK; Clarke-Pearson DL; Iglehart JD; Bast RC; Berchuck A
    Cancer Res; 1991 Jun; 51(11):2979-84. PubMed ID: 2032235
    [TBL] [Abstract][Full Text] [Related]  

  • 13. BRCA2, but not BRCA1, mutations account for familial ovarian cancer in Iceland: a population-based study.
    Rafnar T; Benediktsdottir KR; Eldon BJ; Gestsson T; Saemundsson H; Olafsson K; Salvarsdottir A; Steingrimsson E; Thorlacius S
    Eur J Cancer; 2004 Dec; 40(18):2788-93. PubMed ID: 15571962
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The impact of p53 protein core domain structural alteration on ovarian cancer survival.
    Rose SL; Robertson AD; Goodheart MJ; Smith BJ; DeYoung BR; Buller RE
    Clin Cancer Res; 2003 Sep; 9(11):4139-44. PubMed ID: 14519637
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Registration of primary ovarian cancer in Denmark].
    Petri AL; Høgdall C; Lidegaard O
    Ugeskr Laeger; 2009 Feb; 171(6):408-11. PubMed ID: 19208328
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ovarian cancer: an update on genetics and therapy.
    Penson RT; Shannon KE; Sharpless NE; Seiden MV
    Compr Ther; 1998 Oct; 24(10):477-87. PubMed ID: 9801846
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Clinical staging of ovarian cancer].
    Kato T; Yakushiji M
    Sanfujinka No Jissai; 1971 Dec; 20(13):1223-30. PubMed ID: 5172379
    [No Abstract]   [Full Text] [Related]  

  • 18. Histologic subtypes of ovarian carcinoma: an overview.
    Soslow RA
    Int J Gynecol Pathol; 2008 Apr; 27(2):161-74. PubMed ID: 18317227
    [TBL] [Abstract][Full Text] [Related]  

  • 19. BRCA1 and BRCA2 mutations in Turkish familial and non-familial ovarian cancer patients: a high incidence of mutations in non-familial cases.
    Yazici H; Glendon G; Yazici H; Burnie SJ; Saip P; Buyru F; Bengisu E; Andrulis IL; Dalay N; Ozcelik H
    Hum Mutat; 2002 Jul; 20(1):28-34. PubMed ID: 12112655
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ovarian pathology.
    Talerman A
    Curr Opin Obstet Gynecol; 1992 Aug; 4(4):608-15. PubMed ID: 1504280
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.